Daiwa Securities Group Inc. - PROTAGONIST THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 142 filers reported holding PROTAGONIST THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.34 and the average weighting 0.3%.

Links
Filings
External links
Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of PROTAGONIST THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$7
+16.7%
2150.0%0.00%–
Q1 2024$6
+50.0%
215
+31.9%
0.00%–
Q4 2023$4
+33.3%
1630.0%0.00%–
Q3 2023$3
-40.0%
1630.0%0.00%–
Q2 2023$5
+25.0%
1630.0%0.00%–
Q1 2023$4
+100.0%
1630.0%0.00%–
Q4 2022$2
-99.8%
1630.0%0.00%–
Q3 2022$1,0000.0%1630.0%0.00%–
Q2 2022$1,000
-75.0%
1630.0%0.00%–
Q1 2022$4,000
-33.3%
1630.0%0.00%–
Q4 2021$6,000
+100.0%
1630.0%0.00%–
Q3 2021$3,000
-25.0%
163
+101.2%
0.00%–
Q2 2021$4,000
+100.0%
810.0%0.00%–
Q1 2021$2,0000.0%810.0%0.00%–
Q4 2020$2,000
-50.0%
81
-58.7%
0.00%–
Q3 2020$4,000
+300.0%
196
+27.3%
0.00%–
Q2 2020$1,0000.0%1540.0%0.00%–
Q1 2020$1,0000.0%1540.0%0.00%–
Q4 2019$1,000–154–0.00%–
 Download
Other shareholders
PROTAGONIST THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 2,449,183$84,864,19121.18%
Cannon Global Investment Management, LLC 69,900$2,422,03511.28%
ADAR1 Capital Management, LLC 1,603,932$55,576,24410.49%
Checkpoint Capital L.P. 355,000$12,300,7507.42%
Fairmount Funds Management LLC 931,890$32,289,9893.65%
BVF INC/IL 3,319,290$115,013,3993.22%
RTW INVESTMENTS, LP 5,286,404$183,173,8992.84%
Kynam Capital Management, LP 800,000$27,720,0002.14%
683 Capital Management, LLC 604,449$20,944,1581.58%
Birchview Capital, LP 48,000$1,663,2001.54%
View complete list of PROTAGONIST THERAPEUTICS INC shareholders